Business Wire

VA-DXC-TECHNOLOGY

2.1.2020 10:02:09 CET | Business Wire | Press release

Share
New Shared Mobility Concept, Luxoft HALO, Introduces a Revolutionary Digital, Consumer-Grade In-Vehicle Experience

Luxoft , a DXC Technology Company (NYSE: DXC), today in collaboration with LG Electronics, Amazon and Mapbox unveiled Luxoft HALO, the company’s latest shared mobility concept featuring a revolutionary digital, consumer-grade in-vehicle experience. Luxoft HALO will be formally debuted at CES® 2020, Jan. 7-10, 2020, Las Vegas, NV.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200102005099/en/

At home, consumers expect their digital experiences to be simple, convenient and accessible at any time across a range of devices. Increasingly, consumers also expect access to their favorite content and services, in the vehicle and on the go.

Luxoft HALO shared mobility concept demonstrates how all consumers’ mobility needs can be seamlessly integrated with their personal digital lifestyle.

”Together with our key partners, we can now deliver a complete, highly personalized and intelligent in-vehicle consumer-grade experience, powered by webOS Auto, the platform for shared and intelligent mobility,” said Vildan Hasanbegovic, director of partnerships and head of marketing at Luxoft Automotive. ”It’s an open platform that delivers, with exceptional quality, an existing ecosystem of intelligent services and dynamic content — from in-vehicle infotainment to connected video streaming services and more — that is increasingly becoming an essential part of consumers‘ personal digital lifestyles.”

Luxoft can already deploy webOS Auto to large-scale series production systems, including:

  • Rear Seat Entertainment (RSE) for traditional needs;
  • Rear Seat Entertainment (RSE) with ride-hailing mode;
  • Cabin display for ride-hailing systems; and
  • Center stack display for ride-hailing systems.

Partner Innovations Showcased in Luxoft HALO

LG Electronics and webOS Auto

webOS Auto is an open and ideal platform for shared and intelligent mobility. webOS Auto provides features, and functionality, and incorporates all essential components such as multimedia processing, multi-display control, connectivity, security, offering improved comfort and convenience to passengers.

Alexa Auto

Alexa already helps you simplify and organize your life at home – now you can take her with you on the go with Alexa Auto. Alexa can help you play music, get directions, place calls, listen to audiobooks, control your smart home, and more, with just your voice – so you can keep your hands on the wheel and eyes on the road. Alexa is already available in dozens of vehicles from leading automakers, and Amazon has released services like the Alexa Auto SDK that make it easy for automakers and suppliers to integrate Alexa directly into their infotainment system. To learn more, visit amazon.com/alexa-auto/ .

Mapbox

Mapbox is a live location data platform powering maps and navigation experiences for mobile, web, gaming, and automotive. Mapbox maintains SDKs for developers building for webOS Auto, Android, iOS, Unity 3D, and web, and APIs for rendering maps and performing spatial functions. Every month, over 150,000 developers build with Mapbox. Over 45,000 mobile apps are powered by Mapbox SDKs. Applications and platforms built by developers using Mapbox reach more than 600 million monthly active users.

Luxoft at CES® 2020

Visit Luxoft at CES for a personal, hands-on experience of Luxoft HALO and to experience the future of shared and intelligent mobility; booth #6928, North Hall, Tech East, Las Vegas Convention and World Trade Center.

About Luxoft

Luxoft, a DXC Technology Company, (NYSE: DXC), is a digital strategy and software engineering firm providing bespoke technology solutions that drive business change for customers the world over. Luxoft uses technology to enable business transformation, enhance customer experiences, and boost operational efficiency through its strategy, consulting, and engineering services. Luxoft combines a unique blend of engineering excellence and deep industry expertise, specializing in automotive, financial services, travel and hospitality, healthcare, life sciences, media and telecommunications. For more information, please visit www.luxoft.com .

About DXC Technology

DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. With decades of driving innovation, the world’s largest companies trust DXC to deploy our enterprise technology stack to deliver new levels of performance, competitiveness and customer experiences. Learn more about the DXC story and our focus on people, customers and operational execution at www.dxc.technology .

All information set out in the materials is provided in good faith but does not form part of or constitute an offer or contract. Statements, figures, plans, views and representations are for presentation purposes and indicative only. Luxoft has made reasonable efforts to include accurate information, wherever possible. However, Luxoft makes no warranties or representations, expressed or implied, as to the completeness of the information provided. Luxoft will not be liable for any damages, including but not limited to special or consequential damages, that result from the use of, or the inability to use, the material contained in these materials .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye